These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 25784518

  • 1. Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
    Fauchier L, Marijon E, Defaye P, Piot O, Sadoul N, Perier MC, Gras D, Klug D, Algalarrondo V, Bordachar P, Deharo JC, Leclercq C, Babuty D, Boveda S, DAI-PP Investigators.
    Am J Cardiol; 2015 May 15; 115(10):1415-22. PubMed ID: 25784518
    [Abstract] [Full Text] [Related]

  • 2. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 May 15; 70(11):1099-110. PubMed ID: 23180517
    [Abstract] [Full Text] [Related]

  • 3. Survival after implantable cardioverter-defibrillator implantation in the elderly.
    Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, Krahn AD, Khaykin Y, Cameron D, Chen Z, Lee DS.
    Circulation; 2013 Jun 18; 127(24):2383-92. PubMed ID: 23775193
    [Abstract] [Full Text] [Related]

  • 4. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Jun 18; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 5. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P.
    JAMA; 2007 Jul 25; 298(4):405-12. PubMed ID: 17652294
    [Abstract] [Full Text] [Related]

  • 6. Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD).
    Schaer BA, Kühne MS, Blatter D, Osswald S, Sticherling C.
    Heart; 2014 Mar 25; 100(6):487-91. PubMed ID: 24415667
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S, Sémichon M, Guédon-Moreau L, Drumez É, Kouakam C, Marquié C, Brigadeau F, Kacet S, Potelle C, Escande W, Souissi Z, Lacroix D, Duhamel A, Klug D.
    Arch Cardiovasc Dis; 2016 Oct 25; 109(10):517-526. PubMed ID: 27342808
    [Abstract] [Full Text] [Related]

  • 8. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A, Dorian P, Rakowski H, Care M, Spears D.
    Heart Rhythm; 2021 Jan 25; 18(1):63-70. PubMed ID: 32800967
    [Abstract] [Full Text] [Related]

  • 9. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.
    J Am Coll Cardiol; 2013 Apr 09; 61(14):1527-35. PubMed ID: 23500286
    [Abstract] [Full Text] [Related]

  • 10. Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ≥75 years versus those <75 years.
    Brüllmann S, Dichtl W, Paoli U, Haegeli L, Schmied C, Steffel J, Brunckhorst C, Hintringer F, Seifert B, Duru F, Wolber T.
    Am J Cardiol; 2012 Mar 01; 109(5):712-7. PubMed ID: 22154315
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.
    van Rees JB, Borleffs CJ, Thijssen J, de Bie MK, van Erven L, Cannegieter SC, Bax JJ, Schalij MJ.
    Europace; 2012 Jan 01; 14(1):66-73. PubMed ID: 21920909
    [Abstract] [Full Text] [Related]

  • 12. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R.
    Pacing Clin Electrophysiol; 2009 Mar 01; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [Abstract] [Full Text] [Related]

  • 13. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.
    Rev Esp Cardiol; 2006 Jun 01; 59(6):537-44. PubMed ID: 16790196
    [Abstract] [Full Text] [Related]

  • 14. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF.
    Circ Arrhythm Electrophysiol; 2013 Jun 01; 6(3):562-8. PubMed ID: 23673907
    [Abstract] [Full Text] [Related]

  • 15. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R, Sapp JL, Basta M, Doucette S, Thompson K, Gardner M, Gray C, Brownell B, Kidwai H, Cox J.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):706-13. PubMed ID: 22685111
    [Abstract] [Full Text] [Related]

  • 16. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.
    Circ Arrhythm Electrophysiol; 2013 Jun 01; 6(3):504-12. PubMed ID: 23588627
    [Abstract] [Full Text] [Related]

  • 17. Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators.
    Lee DS, Hardy J, Yee R, Healey JS, Birnie D, Simpson CS, Crystal E, Mangat I, Nanthakumar K, Wang X, Krahn AD, Dorian P, Austin PC, Tu JV, Investigators of the Ontario ICD Database.
    Circ Heart Fail; 2015 Sep 01; 8(5):927-37. PubMed ID: 26224792
    [Abstract] [Full Text] [Related]

  • 18. Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score.
    Kraaier K, Scholten MF, Tijssen JG, Theuns DA, Jordaens LJ, Wilde AA, van Dessel PF.
    Europace; 2014 Jan 01; 16(1):40-6. PubMed ID: 23918791
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Mesquita J, Cavaco D, Ferreira A, Lopes N, Santos PG, Carvalho MS, Haas A, Costa F, Carmo P, Morgado F, Adragão P, Mendes M.
    Int J Cardiol; 2017 Apr 01; 232():176-180. PubMed ID: 28082086
    [Abstract] [Full Text] [Related]

  • 20. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
    Nazer B, Dale Z, Carrassa G, Reza N, Ustunkaya T, Papoutsidakis N, Gray A, Howell SJ, Elman MR, Pieragnoli P, Ricciardi G, Jacoby D, Frankel DS, Owens A, Olivotto I, Heitner SB.
    Heart Rhythm; 2020 Jul 01; 17(7):1107-1114. PubMed ID: 32084597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.